188 related articles for article (PubMed ID: 22447759)
1. The agony of choice: how to find a suitable CPP for cargo delivery.
Müller J; Triebus J; Kretzschmar I; Volkmer R; Boisguerin P
J Pept Sci; 2012 May; 18(5):293-301. PubMed ID: 22447759
[TBL] [Abstract][Full Text] [Related]
2. Transduction of peptides and proteins into live cells by cell penetrating peptides.
Mussbach F; Franke M; Zoch A; Schaefer B; Reissmann S
J Cell Biochem; 2011 Dec; 112(12):3824-33. PubMed ID: 21826709
[TBL] [Abstract][Full Text] [Related]
3. Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells.
Ma DX; Shi NQ; Qi XR
Int J Pharm; 2011 Oct; 419(1-2):200-8. PubMed ID: 21843610
[TBL] [Abstract][Full Text] [Related]
4. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
5. Systemic delivery of BH4 anti-apoptotic peptide using CPPs prevents cardiac ischemia-reperfusion injuries in vivo.
Boisguerin P; Redt-Clouet C; Franck-Miclo A; Licheheb S; Nargeot J; Barrère-Lemaire S; Lebleu B
J Control Release; 2011 Dec; 156(2):146-53. PubMed ID: 21839124
[TBL] [Abstract][Full Text] [Related]
6. Uptake kinetics of cell-penetrating peptides.
Florén A; Mäger I; Langel U
Methods Mol Biol; 2011; 683():117-28. PubMed ID: 21053126
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of cell-penetrating peptides.
Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
[TBL] [Abstract][Full Text] [Related]
8. The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH.
Kim HY; Kim S; Youn H; Chung JK; Shin DH; Lee K
Biomaterials; 2011 Aug; 32(22):5262-8. PubMed ID: 21565400
[TBL] [Abstract][Full Text] [Related]
9. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
[TBL] [Abstract][Full Text] [Related]
10. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Peptide delivery into cells by using the synergistic effects of a cell-penetrating Peptide and a chemical drug to alter cell permeability.
Ma JL; Wang H; Wang YL; Luo YH; Liu CB
Mol Pharm; 2015 Jun; 12(6):2040-8. PubMed ID: 25886885
[TBL] [Abstract][Full Text] [Related]
12. A peptide carrier for the delivery of elastin into fibroblast cells.
Nasrollahi SA; Fouladdel S; Taghibiglou C; Azizi E; Farboud ES
Int J Dermatol; 2012 Aug; 51(8):923-9. PubMed ID: 22788807
[TBL] [Abstract][Full Text] [Related]
13. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
Chugh A; Eudes F; Shim YS
IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
[TBL] [Abstract][Full Text] [Related]
15. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CPP uptake methods.
Holm T; Andaloussi SE; Langel U
Methods Mol Biol; 2011; 683():207-17. PubMed ID: 21053132
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cellular uptake using 22 CPPs in 4 different cell lines.
Mueller J; Kretzschmar I; Volkmer R; Boisguerin P
Bioconjug Chem; 2008 Dec; 19(12):2363-74. PubMed ID: 19053306
[TBL] [Abstract][Full Text] [Related]
18. Quantifying molecular partition of cell-penetrating peptide-cargo supramolecular complexes into lipid membranes: optimizing peptide-based drug delivery systems.
Freire JM; Veiga AS; de la Torre BG; Andreu D; Castanho MA
J Pept Sci; 2013 Apr; 19(4):182-9. PubMed ID: 23322613
[TBL] [Abstract][Full Text] [Related]
19. CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway.
Räägel H; Säälik P; Hansen M; Langel U; Pooga M
J Control Release; 2009 Oct; 139(2):108-17. PubMed ID: 19577599
[TBL] [Abstract][Full Text] [Related]
20. Studies of proteoglycan involvement in CPP-mediated delivery.
Wittrup A; Zhang SH; Belting M
Methods Mol Biol; 2011; 683():99-115. PubMed ID: 21053125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
